Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials (vol 8, pg 169, 2014)

被引：1
|
作者：
Maltais, F.
Singh, S.
Donald, A.
Crater, G.
Church, A.
Goh, A.
机构：
来源：
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | 2016年 / 10卷 / 03期
关键词：
D O I：
10.1177/1753465816640672
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Maltais, F., Singh, S., Donald, A., Crater, G., Church, A., Goh, A. et al. (2014) Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials. Ther Adv Respir Dis 8: 169-181.
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [1] Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials
    Maltais, Francois
    Singh, Sally
    Donald, Alison C.
    Crater, Glenn
    Church, Alison
    Goh, Aik H.
    Riley, John H.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2014, 8 (06) : 169 - 181
  • [2] Effects of a combination of vilanterol and umeclidinium on exercise endurance in subjects with COPD: Two randomised clinical trials
    Maltais, Francois
    Singh, Sally
    Donald, Alison
    Church, Alison
    Crater, Glenn
    Goh, Aik
    Riley, John
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] Therapeutic effects of nebulized verapamil on chronic obstructive pulmonary disease: A randomized and double-blind clinical trial
    Bozorgmehr, Rama
    Edalatifard, Maryam
    Safavi, Enayat
    Rahimi, Besharat
    Ghorbani, Fariba
    Abtahi, Hamidreza
    Amini, Shahideh
    Pourdowlat, Guitti
    CLINICAL RESPIRATORY JOURNAL, 2020, 14 (04): : 370 - 381
  • [4] Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies (vol 109, pg 1155, 2015)
    Siler, Thomas M.
    Kerwin, Edward
    Sousa, Ana R.
    Donald, Alison
    Ali, Rehan
    Church, Alison
    RESPIRATORY MEDICINE, 2015, 109 (11) : 1493 - 1493
  • [5] Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study
    Pelaia, Corrado
    Bannera, Anna Ferrante
    Rotundo, Fioramante Lello
    Tropea, Francesco Giuseppe
    Armentaro, Giuseppe
    Maglio, Angelantonio
    Sciacqua, Angela
    Vatrella, Alessandro
    Pelaia, Girolamo
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 995 - 1002
  • [6] Clinical and functional effects of inhaled dual therapy umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease: a real-life study
    Pelaia, Corrado
    Bannera, Anna Ferrante
    Rotundo, Fioramante Lello
    Tropea, Francesco Giuseppe
    Armentaro, Giuseppe
    Maglio, Angelantonio
    Sciacqua, Angela
    Vatrella, Alessandro
    Pelaia, Girolamo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [7] Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
    Decramer, Marc
    Anzueto, Antonio
    Kerwin, Edward
    Kaelin, Thomas
    Richard, Nathalie
    Crater, Glenn
    Tabberer, Maggie
    Harris, Stephanie
    Church, Alison
    LANCET RESPIRATORY MEDICINE, 2014, 2 (06): : 472 - 486
  • [8] Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study
    James F Donohue
    Dennis Niewoehner
    Jean Brooks
    Dianne O’Dell
    Alison Church
    Respiratory Research, 15
  • [9] Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study
    Donohue, James F.
    Niewoehner, Dennis
    Brooks, Jean
    O'Dell, Dianne
    Church, Alison
    RESPIRATORY RESEARCH, 2014, 15
  • [10] TERBUTALINE AND DIAPHRAGM FUNCTION IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE - A DOUBLE-BLIND RANDOMIZED CLINICAL-TRIAL
    STOLLER, JK
    WIEDEMANN, HP
    LOKE, J
    SNYDER, P
    VIRGULTO, J
    MATTHAY, RA
    BRITISH JOURNAL OF DISEASES OF THE CHEST, 1988, 82 (03): : 243 - 250
12345